Invesco Ltd. Compass Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 35,465 shares of CMPX stock, worth $56,389. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,465

Previous 37,402 5.18%

Holding current value

$56,389

Previous $37,000 75.68%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.8 - $1.88 $1,549 - $3,641	-1,937 Reduced 5.18%	35,465 $65,000
Q2 2024 Aug 13, 2024	SELL	$1.0 - $1.85 $4,361 - $8,067	-4,361 Reduced 10.44%	37,402 $37,000
Q1 2024 May 14, 2024	SELL	$1.2 - $2.29 $1,712 - $3,267	-1,427 Reduced 3.3%	41,763 $82,000
Q4 2023 Feb 12, 2024	SELL	$1.4 - $1.98 $32,068 - $45,353	-22,906 Reduced 34.66%	43,190 $67,000
Q3 2023 Nov 13, 2023	BUY	$1.87 - $3.25 $51,335 - $89,219	27,452 Added 71.04%	66,096 $130,000
Q2 2023 Aug 11, 2023	BUY	$2.64 - $3.48 $102,020 - $134,481	38,644 New	38,644 $122,000

Others Institutions Holding CMPX

# of Institutions

Shares Held

92M

Call Options Held

Put Options Held

View Full List

About Compass Therapeutics, Inc.

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $161M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

More about CMPX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account